Literature DB >> 24252442

A 3-lever discrimination procedure reveals differences in the subjective effects of low and high doses of MDMA.

David N Harper1, Anna-Lena Langen2, Susan Schenk2.   

Abstract

Drug discrimination studies have suggested that the subjective effects of low doses of (±)3,4-methylenedioxymethamphetamine (MDMA) are readily differentiated from those of d-amphetamine (AMPH) and that the discriminative stimulus properties are mediated by serotonergic and dopaminergic mechanisms, respectively. Previous studies, however, have primarily examined responses to doses that do not produce substantial increases in extracellular dopamine. The present study determined whether doses of MDMA that produce increases in synaptic dopamine would also produce subjective effects that were more like AMPH and were sensitive to pharmacological manipulation of D1-like receptors. A three-lever drug discrimination paradigm was used. Rats were trained to respond on different levers following saline, AMPH (0.5mg/kg, IP) or MDMA (1.5mg/kg, IP) injections. Generalization curves were generated for a range of different doses of both drugs and the effect of the D1-like antagonist, SCH23390 on the discriminative stimulus effects of different doses of MDMA was determined. Rats accurately discriminated MDMA, AMPH and saline. Low doses of MDMA produced almost exclusive responding on the MDMA lever but at doses of 3.0mg/kg MDMA or higher, responding shifted to the AMPH lever. The AMPH response produced by higher doses of MDMA was attenuated by pretreatment with SCH23390. The data suggest that low doses and higher doses of MDMA produce distinct discriminative stimuli. The shift to AMPH-like responding following administration of higher doses of MDMA, and the decrease in this response following administration of SCH23390 suggests a dopaminergic component to the subjective experience of MDMA at higher doses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Drug discrimination; MDMA; SCH23390; d-Amphetamine

Mesh:

Substances:

Year:  2013        PMID: 24252442     DOI: 10.1016/j.pbb.2013.11.011

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.

Authors:  Sean B Dolan; Zhenglan Chen; Renqi Huang; Michael B Gatch
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

2.  Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2016-09       Impact factor: 2.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.